THE COOPER COMPANIES, INC. Funds and ETFs The Cooper Companies, Inc.
Equities
COO
US2166485019
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 92.14 USD | -1.36% |
|
+2.60% | -2.77% |
| Apr. 03 | Citigroup Raises Price Target on Cooper Companies to $116 From $108, Keeps Buy Rating | MT |
| Mar. 21 | Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing | MT |
ETFs positioned on The Cooper Companies, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 0 M€ | +6.13% | - | |
| 0.05% | 0 M€ | +11.71% | - | |
| 0.05% | 0 M€ | +11.40% | - | |
| 0.04% | 23 M€ | -.--% | - | |
| 0.04% | 786 M€ | -.--% | ||
| 0.04% | 1 M€ | -.--% | ||
| 0.04% | 14 M€ | +16.19% | - | |
| 0.04% | 0 M€ | +18.67% | - | |
| 0.04% | 1,174 M€ | +23.54% | ||
| 0.04% | 273 M€ | -.--% | ||
| 0.04% | 655 M€ | -.--% | - | |
| 0.04% | 0 M€ | 0.00% | - | |
| 0.04% | 206 M€ | -.--% | ||
| 0.04% | 284 M€ | -.--% | ||
| 0.03% | 205 M€ | -.--% | ||
| 0.03% | 0 M€ | +16.98% | ||
| 0.03% | 1,166 M€ | +0.26% | - | |
| 0.03% | 607 M€ | +0.05% | - | |
| 0.02% | 0 M€ | +8.21% | - | |
| 0.02% | 0 M€ | +6.06% | - | |
| 0.02% | 0 M€ | +7.77% | - | |
| 0.02% | 0 M€ | +5.23% | - | |
| 0.02% | 0 M€ | +4.96% | - | |
| 0.01% | 0 M€ | +3.41% | - |
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
2024-05-30
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
93.42
USD
Average target price
107.9
USD
Spread / Average Target
+15.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.77% | 18.57B | |
| +11.12% | 39.88B | |
| -14.88% | 2.42B | |
| -11.42% | 1.5B | |
| +24.21% | 1.19B | |
| -34.38% | 778M | |
| -35.31% | 752M | |
| -8.66% | 671M | |
| +26.26% | 511M | |
| +23.80% | 486M |
- Stock Market
- Equities
- COO Stock
- Funds and ETFs The Cooper Companies, Inc.